[Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Recommendations for supportive therapy for Sjögren's syndrome].
For the treatment of sicca symptoms as a manifestation of Sjögren's syndrome there are various tear substitutes as well as artificial saliva. The appropriate substances are discussed in this article. In addition to reducing symptoms, some of the effective compounds offer the advantage of infection prophylaxis in the form of better lubrication of the mucous membranes in the airways as well as reduced susceptibility to candidiasis. The presence of bromhexin in the catalogue of the statutory medical insurance agencies is recommended. Certain of the available drugs are still only available in foreign pharmacies.
Gause
A
A
Internistisch-Rheumatologische Schwerpunktpraxis, Elmshorn. amgause@t-online.de
D001964:Bromhexine / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D015352:Dry Eye Syndromes / Q000628:therapy*; D004599:Electric Stimulation Therapy; D005100:Expectorants / Q000627:therapeutic use; D006801:Humans; D018727:Muscarinic Antagonists / Q000008:administration & dosage; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D010862:Pilocarpine / Q000008:administration & dosage; D011812:Quinuclidines / Q000008:administration & dosage; D012859:Sjogren's Syndrome / Q000628:therapy*; D013876:Thiophenes / Q000008:administration & dosage; D014987:Xerostomia / Q000628:therapy*
D005100:Expectorants; D018727:Muscarinic Antagonists; D009883:Ophthalmic Solutions; D011812:Quinuclidines; D013876:Thiophenes; D010862:Pilocarpine; D016572:Cyclosporine; C059240:cevimeline; D001964:Bromhexine